198 related articles for article (PubMed ID: 33483464)
21. CSN6 drives carcinogenesis by positively regulating Myc stability.
Chen J; Shin JH; Zhao R; Phan L; Wang H; Xue Y; Post SM; Ho Choi H; Chen JS; Wang E; Zhou Z; Tseng C; Gully C; Velazquez-Torres G; Fuentes-Mattei E; Yeung G; Qiao Y; Chou PC; Su CH; Hsieh YC; Hsu SL; Ohshiro K; Shaikenov T; Wang H; Yeung SC; Lee MH
Nat Commun; 2014 Nov; 5():5384. PubMed ID: 25395170
[TBL] [Abstract][Full Text] [Related]
22. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.
Chen B; Zhao R; Su CH; Linan M; Tseng C; Phan L; Fang L; Yang HY; Yang H; Wang W; Xu X; Jiang N; Cai S; Jin F; Yeung SC; Lee MH
Cell Cycle; 2012 Dec; 11(24):4633-41. PubMed ID: 23187808
[TBL] [Abstract][Full Text] [Related]
23. CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16
Du W; Liu Z; Zhu W; Li T; Zhu Z; Wei L; Song J; Pei D
Cancer Biol Med; 2019 Aug; 16(3):514-529. PubMed ID: 31565481
[TBL] [Abstract][Full Text] [Related]
24. CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis.
Shi J; Guan X; Zhan F; Liu C; Li Z; Yao Y; Wang B; Lou C; Zhang Y
Cancer Biol Ther; 2019; 20(9):1290-1299. PubMed ID: 31311398
[TBL] [Abstract][Full Text] [Related]
25. ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development.
Fang L; Lu W; Choi HH; Yeung SC; Tung JY; Hsiao CD; Fuentes-Mattei E; Menter D; Chen C; Wang L; Wang J; Lee MH
Cancer Cell; 2015 Aug; 28(2):183-97. PubMed ID: 26267535
[TBL] [Abstract][Full Text] [Related]
26. CSN6, a subunit of the COP9 signalosome, is involved in early response to iron deficiency in Oryza sativa.
Tan S; Liu F; Pan XX; Zang YP; Jin F; Zu WX; Qi XT; Xiao W; Yin LP
Sci Rep; 2016 May; 6():25485. PubMed ID: 27137867
[TBL] [Abstract][Full Text] [Related]
27. COP9 signalosome subunit 6 mediates PDGF -induced pulmonary arterial smooth muscle cells proliferation.
Zhu Y; Li F; Shi W; Zhai C; Wang J; Yan X; Wang Q; Zhang Q; Yang L; Gao L; Li M
Exp Cell Res; 2018 Oct; 371(2):379-388. PubMed ID: 30180991
[TBL] [Abstract][Full Text] [Related]
28. The COP9 signalosome subunit 6 (CSN6): a potential oncogene.
Zhang SN; Pei DS; Zheng JN
Cell Div; 2013 Nov; 8(1):14. PubMed ID: 24286178
[TBL] [Abstract][Full Text] [Related]
29. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
30. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
31. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
33. CSN6: a promising target for cancer prevention and therapy.
Hou J; Cui H
Histol Histopathol; 2020 Jul; 35(7):645-652. PubMed ID: 32016946
[TBL] [Abstract][Full Text] [Related]
34. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
35. Desmosomal COP9 regulates proteome degradation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Liang Y; Lyon RC; Pellman J; Bradford WH; Lange S; Bogomolovas J; Dalton ND; Gu Y; Bobar M; Lee MH; Iwakuma T; Nigam V; Asimaki A; Scheinman M; Peterson KL; Sheikh F
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 33857019
[TBL] [Abstract][Full Text] [Related]
36. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
[TBL] [Abstract][Full Text] [Related]
37. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53.
Xue Y; Chen J; Choi HH; Phan L; Chou PC; Zhao R; Yang H; Santiago J; Liu M; Yeung GE; Yeung SC; Lee MH
Cell Cycle; 2012 Nov; 11(22):4181-90. PubMed ID: 23095642
[TBL] [Abstract][Full Text] [Related]
38. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
Front Oncol; 2021; 11():634167. PubMed ID: 33777788
[TBL] [Abstract][Full Text] [Related]
39. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
40. EGF Relays Signals to COP1 and Facilitates FOXO4 Degradation to Promote Tumorigenesis.
Choi HH; Zou S; Wu JL; Wang H; Phan L; Li K; Zhang P; Chen D; Liu Q; Qin B; Nguyen TAT; Yeung SJ; Fang L; Lee MH
Adv Sci (Weinh); 2020 Oct; 7(20):2000681. PubMed ID: 33101846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
